Clinical chemistry (Baltimore, Md.), 2002-08, Vol.48 (8), p.1360-1362
2002
Details
- Autor(en) / Beteiligte
- Titel
- Serologic concentrations of HER-2/neu in breast cancer patients with visceral metastases receiving trastuzumab therapy predict the clinical course
- Ist Teil von
- Clinical chemistry (Baltimore, Md.), 2002-08, Vol.48 (8), p.1360-1362
- Ort / Verlag
- Washington, DC: American Association for Clinical Chemistry
- Erscheinungsjahr
- 2002
- Link zum Volltext
- Quelle
- Oxford Journals 2020 Medicine
- Sprache
- Englisch
- Identifikatoren
- ISSN: 0009-9147eISSN: 1530-8561DOI: 10.1093/clinchem/48.8.1360Titel-ID: cdi_proquest_miscellaneous_71953554
- Format
- –
- Schlagworte
- Adult, Aged, Antibodies, Monoclonal - therapeutic use, Antibodies, Monoclonal, Humanized, Antimitotic agents, Antineoplastic agents, Antineoplastic Agents - therapeutic use, Biological and medical sciences, Biomarkers, Tumor - blood, Breast cancer, Breast Neoplasms - diagnosis, Breast Neoplasms - drug therapy, Breast Neoplasms - pathology, Cancer, Cancer patients, Development and progression, Female, Genetic aspects, Gynecology. Andrology. Obstetrics, Humans, Immunohistochemistry, Mammary gland diseases, Medical research, Medical sciences, Medicine, Experimental, Metastasis, Middle Aged, Mucin-1 - blood, Neoplasm Metastasis, Prognosis, Receptor, ErbB-2 - blood, Trastuzumab, Tumors, Viscera